Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED

Cellebrite DI (CLBT)

Upturn stock ratingUpturn stock rating
Cellebrite DI
$21.29
Delayed price
Today's Top Picks Today’s top pick
Profit since last BUY73.94%
Strong Buy
upturn advisory
BUY since 130 days
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

12/19/2024: CLBT (5-star) is a STRONG-BUY. BUY since 130 days. Profits (73.94%). Updated daily EoD!

Analysis of Past Performance​

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: Strong Buy
Historic Profit: 89.39%
Upturn Advisory Performance Upturn Advisory Performance3
Avg. Invested days: 55
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 4
Last Close 12/19/2024
Type: Stock
Today’s Advisory: Strong Buy
Historic Profit: 89.39%
Avg. Invested days: 55
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 4
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 12/19/2024
Upturn Advisory Performance Upturn Advisory Performance3

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 4.57B USD
Price to earnings Ratio -
1Y Target Price 23
Dividends yield (FY) -
Basic EPS (TTM) -1.58
Volume (30-day avg) 1474018
Beta 1.5
52 Weeks Range 7.91 - 22.63
Updated Date 12/20/2024
Company Size Mid-Cap Stock
Market Capitalization 4.57B USD
Price to earnings Ratio -
1Y Target Price 23
Dividends yield (FY) -
Basic EPS (TTM) -1.58
Volume (30-day avg) 1474018
Beta 1.5
52 Weeks Range 7.91 - 22.63
Updated Date 12/20/2024

Earnings Date

Report Date -
When -
Estimate -
Actual -
Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -82.28%
Operating Margin (TTM) 18.2%

Management Effectiveness

Return on Assets (TTM) 6.35%
Return on Equity (TTM) -188.5%

Revenue by Products

Revenue by Products - Current and Previous Year

Revenue by Geography

Revenue by Geography - Current and Previous Year

Valuation

Trailing PE -
Forward PE 37.17
Enterprise Value 4215519960
Price to Sales(TTM) 11.88
Enterprise Value to Revenue 10.94
Enterprise Value to EBITDA 93.78
Shares Outstanding 214843008
Shares Floating 84356510
Percent Insiders 46.79
Percent Institutions 52.97
Trailing PE -
Forward PE 37.17
Enterprise Value 4215519960
Price to Sales(TTM) 11.88
Enterprise Value to Revenue 10.94
Enterprise Value to EBITDA 93.78
Shares Outstanding 214843008
Shares Floating 84356510
Percent Insiders 46.79
Percent Institutions 52.97

Analyst Ratings

Rating 4.75
Target Price 9.8
Buy 2
Strong Buy 6
Hold -
Sell -
Strong Sell -
Rating 4.75
Target Price 9.8
Buy 2
Strong Buy 6
Hold -
Sell -
Strong Sell -

AI Summarization

Cellebrite DI: A Comprehensive Overview

Company Profile:

History and Background:

  • Founded in 1999, Cellebrite DI (CLBT) is an Israeli-based company specializing in digital intelligence solutions.
  • Originally focused on data extraction from mobile devices for law enforcement, the company has expanded its offerings to serve various industries.
  • In 2019, Cellebrite merged with Blackstone’s portfolio company, The Access Company, to become Cellebrite DI.

Core Business Areas:

  • Digital Intelligence Solutions:
    • Forensic Tools: Extracting data from mobile devices for law enforcement and investigations.
    • Intelligence Solutions: Analyzing data to identify patterns, trends, and insights.
    • Cloud Solutions: Securing and managing data in the cloud.
  • Government and Enterprise Solutions:
    • Serving government agencies and enterprises in sectors like finance, healthcare, and retail.
    • Focuses on data privacy and compliance, cybercrime prevention, and fraud investigation.

Leadership Team and Corporate Structure:

  • CEO: Yossi Carmil
  • President and COO: Ron Serber
  • CFO: Moshe Tzuk
  • The company operates in a diversified corporate structure with subsidiaries globally.

Top Products and Market Share:

Top Products:

  • UFED Series: Leading forensic toolkit for extracting data from mobile devices.
  • BlackLight: Cloud-based platform for managing and analyzing digital evidence.
  • Guardian: Data extraction and analysis solution for enterprises.

Market Share:

  • Holds a dominant global market share in the mobile forensics market, estimated at over 60%.
  • Expanding into new markets within government and enterprise segments, where market share is less established.

Product Performance and Comparison:

  • UFED Series consistently praised for its data extraction capabilities and user-friendliness.
  • BlackLight recognized for its scalability and cloud-based functionality.
  • Competition exists from companies like Magnet Forensics and Grayshift, offering similar solutions.

Total Addressable Market:

  • The global digital forensics market is estimated to be worth over $5 billion in 2023 and is projected to grow at a CAGR of over 10% through 2028.
  • The enterprise segment, which Cellebrite is actively targeting, represents a significant portion of this market.

Financial Performance:

  • Revenue increased by 22% year-over-year in 2022, reaching $246 million.
  • Net income of $53 million in 2022, with a profit margin of 21.5%.
  • EPS for 2022 was $0.44.
  • Strong cash flow from operations and healthy balance sheet.

Dividends and Shareholder Returns:

  • No dividend history.
  • Total shareholder return of 58% over the past year.

Growth Trajectory:

  • Historical growth driven by the UFED Series and law enforcement adoption.
  • Future growth hinges on successful expansion into government and enterprise markets.
  • Recent product launches, including Guardian, and strategic partnerships aiming to fuel growth.

Market Dynamics:

  • Increasing demand for digital forensics solutions across various industries.
  • Technological advancements drive innovation and competition in the market.
  • Data privacy regulations and ethical concerns impact industry dynamics.

Cellebrite DI is well-positioned within the market due to its:

  • Strong brand recognition and leading market share.
  • Expanding product portfolio with cloud-based solutions.
  • Growth through government and enterprise market penetration.

Competitors:

  • Magnet Forensics (MAGT): Leading competitor in mobile forensics market.
  • Grayshift: Known for GrayKey, a controversial iPhone unlocking tool.
  • MSAB: Offers forensic tools and services for law enforcement.
  • Other smaller players: Targeting specific market segments.

Key Challenges and Opportunities:

Challenges:

  • Maintaining market leadership in the face of competition.
  • Adapting to evolving technology and data privacy regulations.
  • Balancing ethical considerations with market needs.

Opportunities:

  • Expanding into new markets (e.g., cybersecurity, fraud detection).
  • Further developing cloud-based solutions and partnerships.
  • Leveraging AI and machine learning to enhance data analysis capabilities.

Recent Acquisitions:

  • 2021: Acquired BlackBag Technologies, strengthening its cloud-based digital forensics offerings.
  • 2021: Acquired Guardian Digital Forensics, expanding its enterprise software and solutions portfolio.
  • 2022: Acquired XCellint Solutions, a specialist in mobile device acquisition and analysis.
  • These acquisitions align with Cellebrite DI's growth strategy of expanding its product portfolio and entering new markets.

AI-Based Fundamental Rating:

  • AI-Based Rating: 7/10
  • Justification: Cellebrite DI benefits from a strong market position, robust financials, and growth potential. However, challenges from competitors and ethical considerations necessitate continuous adaptation.

Sources and Disclaimers:

  • This overview utilizes data from Cellebrite DI's investor relations page, SEC filings, news articles, and market research reports.
  • This information is provided for educational purposes only. It is not financial advice and should not be construed as a recommendation to invest in Cellebrite DI or any other company. Investors should conduct their own due diligence before making any investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Cellebrite DI

Exchange NASDAQ Headquaters -
IPO Launch date 2021-08-31 Founder, CEO & Director Mr. Yossi Carmil
Sector Technology Website https://www.cellebrite.com
Industry Software - Infrastructure Full time employees 1008
Headquaters -
Founder, CEO & Director Mr. Yossi Carmil
Website https://www.cellebrite.com
Website https://www.cellebrite.com
Full time employees 1008

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Mobile Now; and professional services, such as training and certification services, and other services. It serves federal and state and local agencies. The company is headquartered in Petah Tikva, Israel.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​